BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27390927)

  • 21. MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.
    Zanotti L; Romani C; Tassone L; Todeschini P; Tassi RA; Bandiera E; Damia G; Ricci F; Ardighieri L; Calza S; Marchini S; Beltrame L; Tognon G; D'Incalci M; Pecorelli S; Sartori E; Odicino F; Ravaggi A; Bignotti E
    BMC Cancer; 2017 May; 17(1):366. PubMed ID: 28545541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
    He QZ; Luo XZ; Wang K; Zhou Q; Ao H; Yang Y; Li SX; Li Y; Zhu HT; Duan T
    Cell Physiol Biochem; 2014; 33(1):173-84. PubMed ID: 24504111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of FRZB on growth and metastasis of gastric cancer cell line SGC-7901].
    Qu Y; Li JF; Cai Q; Liu BY; Zhu ZG
    Ai Zheng; 2008 Aug; 27(8):795-802. PubMed ID: 18710611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
    Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
    Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro.
    Strobel T; Cannistra SA
    Gynecol Oncol; 1999 Jun; 73(3):362-7. PubMed ID: 10366461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
    Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW; Spong SM; Scarlett CJ; Hacker NF; Ghosh S; Mok SC; Birrer MJ; Samimi G
    Oncotarget; 2015 Dec; 6(42):44551-62. PubMed ID: 26575166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-2 cleavage of the β1 integrin ectodomain facilitates colon cancer cell motility.
    Kryczka J; Stasiak M; Dziki L; Mik M; Dziki A; Cierniewski C
    J Biol Chem; 2012 Oct; 287(43):36556-66. PubMed ID: 22898815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin.
    Moser TL; Pizzo SV; Bafetti LM; Fishman DA; Stack MS
    Int J Cancer; 1996 Sep; 67(5):695-701. PubMed ID: 8782661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
    Gong C; Yang Z; Wu F; Han L; Liu Y; Gong W
    Oncol Rep; 2016 Oct; 36(4):2177-83. PubMed ID: 27499367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer.
    Chu Y; Tang H; Guo Y; Guo J; Huang B; Fang F; Cai J; Wang Z
    Exp Cell Res; 2015 Sep; 337(1):16-27. PubMed ID: 26209607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
    Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
    Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
    Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS
    Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells.
    Wantoch von Rekowski K; König P; Henze S; Schlesinger M; Zawierucha P; Januchowski R; Bendas G
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
    Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
    Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells.
    Zhou Y; Chen X; Kang B; She S; Zhang X; Chen C; Li W; Chen W; Dan S; Pan X; Liu X; He J; Zhao Q; Zhu C; Peng L; Wang H; Yao H; Cao H; Li L; Herlyn M; Wang YJ
    Cell Death Dis; 2018 May; 9(6):585. PubMed ID: 29789579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin.
    Ellerbroek SM; Fishman DA; Kearns AS; Bafetti LM; Stack MS
    Cancer Res; 1999 Apr; 59(7):1635-41. PubMed ID: 10197640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.
    Raghavan S; Mehta P; Xie Y; Lei YL; Mehta G
    J Immunother Cancer; 2019 Jul; 7(1):190. PubMed ID: 31324218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
    Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
    Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer.
    Yin M; Li X; Tan S; Zhou HJ; Ji W; Bellone S; Xu X; Zhang H; Santin AD; Lou G; Min W
    J Clin Invest; 2016 Nov; 126(11):4157-4173. PubMed ID: 27721235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.